{"title":"Liquid-liquid phase separation in cancer radiotherapy and immunotherapy: emerging roles and translational opportunities","authors":"Chenchen Dong,Cong Shang,Bing Han,Ziyi Liu,Jiaoyang Wang,Peng Cao,Juan Zeng,Ayao Guo,Xiufang Ren,Shuo Cao","doi":"10.1186/s12943-026-02813-4","DOIUrl":null,"url":null,"abstract":"Abstract Liquid-liquid phase separation (LLPS) is a physicochemical process through which biomolecules assemble into membraneless condensates via weak, multivalent interactions. LLPS has emerged as a central biological principle that helps explain intracellular spatiotemporal compartmentalization, signal transduction, and stress responses. Dysregulated LLPS contributes to tumor initiation, progression, immune evasion, and treatment resistance; however, its cell-type-specific functions and relevance to radiotherapy and immunotherapy remain incompletely integrated. In this review, we critically synthesize recent mechanistic and translational advances linking LLPS to cancer radiotherapy and immunotherapy. Condensates may either support therapeutic resistance and immune evasion or enhance radiosensitivity and antitumor immunity, depending on their molecular composition, subcellular localization, cell type, and treatment context. We examine how condensate regulation connects radiation-induced DNA damage repair with innate immune activation and evaluate emerging therapeutic strategies that target disease-associated condensates. We also assess LLPS-associated abnormal condensates as candidate biomarkers for prognosis and prediction of tumor response to radiotherapy and immunotherapy. Tissue-specific LLPS regulation across tumor types, dynamic condensate remodeling under therapeutic stress, and rational strategies combining phase-separation modulation with immune-checkpoint inhibitors and radiotherapy require further investigation. Integrating multi-omics data with artificial intelligence-based algorithms may help construct systematic LLPS-related therapeutic-event maps and predictive models, thereby prioritizing experimentally testable hypotheses for personalized cancer management. With rigorous mechanistic validation and prospective clinical evaluation, selective modulation of disease-associated condensates may enhance radiosensitivity and strengthen antitumor immunity.","PeriodicalId":19000,"journal":{"name":"Molecular Cancer","volume":"22 1","pages":""},"PeriodicalIF":42.2000,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12943-026-02813-4","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Abstract Liquid-liquid phase separation (LLPS) is a physicochemical process through which biomolecules assemble into membraneless condensates via weak, multivalent interactions. LLPS has emerged as a central biological principle that helps explain intracellular spatiotemporal compartmentalization, signal transduction, and stress responses. Dysregulated LLPS contributes to tumor initiation, progression, immune evasion, and treatment resistance; however, its cell-type-specific functions and relevance to radiotherapy and immunotherapy remain incompletely integrated. In this review, we critically synthesize recent mechanistic and translational advances linking LLPS to cancer radiotherapy and immunotherapy. Condensates may either support therapeutic resistance and immune evasion or enhance radiosensitivity and antitumor immunity, depending on their molecular composition, subcellular localization, cell type, and treatment context. We examine how condensate regulation connects radiation-induced DNA damage repair with innate immune activation and evaluate emerging therapeutic strategies that target disease-associated condensates. We also assess LLPS-associated abnormal condensates as candidate biomarkers for prognosis and prediction of tumor response to radiotherapy and immunotherapy. Tissue-specific LLPS regulation across tumor types, dynamic condensate remodeling under therapeutic stress, and rational strategies combining phase-separation modulation with immune-checkpoint inhibitors and radiotherapy require further investigation. Integrating multi-omics data with artificial intelligence-based algorithms may help construct systematic LLPS-related therapeutic-event maps and predictive models, thereby prioritizing experimentally testable hypotheses for personalized cancer management. With rigorous mechanistic validation and prospective clinical evaluation, selective modulation of disease-associated condensates may enhance radiosensitivity and strengthen antitumor immunity.
期刊介绍:
Molecular Cancer is a platform that encourages the exchange of ideas and discoveries in the field of cancer research, particularly focusing on the molecular aspects. Our goal is to facilitate discussions and provide insights into various areas of cancer and related biomedical science. We welcome articles from basic, translational, and clinical research that contribute to the advancement of understanding, prevention, diagnosis, and treatment of cancer.
The scope of topics covered in Molecular Cancer is diverse and inclusive. These include, but are not limited to, cell and tumor biology, angiogenesis, utilizing animal models, understanding metastasis, exploring cancer antigens and the immune response, investigating cellular signaling and molecular biology, examining epidemiology, genetic and molecular profiling of cancer, identifying molecular targets, studying cancer stem cells, exploring DNA damage and repair mechanisms, analyzing cell cycle regulation, investigating apoptosis, exploring molecular virology, and evaluating vaccine and antibody-based cancer therapies.
Molecular Cancer serves as an important platform for sharing exciting discoveries in cancer-related research. It offers an unparalleled opportunity to communicate information to both specialists and the general public. The online presence of Molecular Cancer enables immediate publication of accepted articles and facilitates the presentation of large datasets and supplementary information. This ensures that new research is efficiently and rapidly disseminated to the scientific community.